SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The June 2024 quarter revenue stood at Rs. 58412.00 millions, up 7.43% as compared to Rs. 54373.00 millions during the corresponding quarter last year.A slender decline of -13.55% was recorded to Rs. 14172.00  millions from Rs. 16394.00 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 21708.00 millions from 24613.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 58412.00 54373.00 7.43 58412.00 54373.00 7.43 194838.00 169625.00 14.86
Other Income 2178.00 2336.00 -6.76 2178.00 2336.00 -6.76 8623.00 5913.00 45.83
PBIDT 21708.00 24613.00 -11.80 21708.00 24613.00 -11.80 67887.00 48061.00 41.25
Interest 71.00 45.00 57.78 71.00 45.00 57.78 218.00 169.00 28.99
PBDT 21637.00 24568.00 -11.93 21637.00 24568.00 -11.93 67669.00 47892.00 41.29
Depreciation 2498.00 2372.00 5.31 2498.00 2372.00 5.31 9756.00 9232.00 5.68
PBT 19139.00 22196.00 -13.77 19139.00 22196.00 -13.77 57913.00 38660.00 49.80
TAX 4967.00 5802.00 -14.39 4967.00 5802.00 -14.39 14493.00 12532.00 15.65
Deferred Tax 301.00 415.00 -27.47 301.00 415.00 -27.47 875.00 3891.00 -77.51
PAT 14172.00 16394.00 -13.55 14172.00 16394.00 -13.55 43420.00 26128.00 66.18
Equity 834.00 833.00 0.12 834.00 833.00 0.12 834.00 833.00 0.12
PBIDTM(%) 37.16 45.27 -17.90 37.16 45.27 -17.90 34.84 28.33 22.97

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×